• 3d printing
  • 5g
  • Abortion
  • Aco
  • Addiction
  • Ai
  • Alexa
  • Alzheimers
  • Amzon
  • Antibiotic resistance
  • Anxiety
  • Api
  • Augmented reality
  • Autism
  • Awards
  • Big data
  • Biohacking
  • Blockchain
  • Breast cancer
  • Burnout
  • Business model
  • Byod
  • Cancer
  • Care
  • Care model
  • Career hit job market
  • Ccm
  • Cdc
  • Cerner
  • Challenge
  • Chatbots
  • Chromosomes
  • Chronic
  • Chronic illness
  • Chronic pain
  • Cio
  • Claims data
  • Clinical data
  • Clinical decision support
  • Clinical research
  • Clinical setting
  • Clinical trials
  • Clinician
  • Cloud
  • Cmo
  • Cms
  • Companies
  • Compliance
  • Consumerism
  • Coronavirus
  • Cost
  • Covid 19
  • Cpt
  • Crispr
  • Cybersecurity
  • Data
  • Data analytics
  • Data breach
  • Data privacy
  • Data sharing
  • Database
  • Dementia
  • Dental it
  • Depression
  • Dermatology
  • Device
  • Diabetes
  • Digital health
  • Digital health funding
  • Digital health leadership
  • Digital humanism
  • Digital therapeutic
  • Digital tool
  • Disease outbreak
  • Dna fingerprinting
  • Doctor
  • Doctors
  • Drones
  • Drug reaction
  • Drugs
  • E portal
  • Ehr
  • Elderly
  • Emergency
  • Emergency medicine
  • Emr
  • Encryption
  • Eprescribing
  • Event
  • Events
  • Evidence
  • Facial recognition
  • Fda
  • Femtech
  • Fhir
  • Funding
  • Gateway
  • Gene editing
  • Genetic counselling
  • Genomics
  • Google
  • Governance and regulations
  • Government
  • Hea
  • Health data
  • Health information exchange
  • Health law
  • Healthcare
  • Healthcare automation
  • Healthcare it
  • Healthcare providers
  • Healthcare trends
  • Healthimpact
  • Hhs
  • Himss
  • Himss 19
  • Himss20
  • Hipaa
  • Hitech
  • Hiv
  • Hl7
  • Home care
  • Home lab tests
  • Home monitoring tool
  • Hospital
  • Hospital at home
  • Hospital discharge
  • Hospital readmissions
  • Hospital systems
  • Hospitals
  • Humour
  • Imaging
  • Immunisation
  • Immunity
  • Immunization
  • Infographics
  • Innovation
  • Inpatient imaging
  • Insight
  • Insurance billing
  • Integrated omics
  • Interoperability
  • Interview
  • Investor
  • Iot
  • It
  • Just in
  • Layoff
  • Longevity
  • Ltpac
  • Machine learning
  • Market research
  • Meaningful use
  • Medicaid
  • Medical data
  • Medical device
  • Medical device security
  • Medical devices
  • Medical education
  • Medical errors
  • Medical imaging
  • Medical innovation
  • Medical library
  • Medical practice
  • Medical record
  • Medical science
  • Medical speciality
  • Medicare
  • Medication management
  • Medicine
  • Medigy
  • Medte
  • Medtech
  • Mental health
  • Merger
  • Mergers and acquisitions
  • Mhealth
  • Mhealth app
  • Microsoft cloud
  • Mips
  • Misdiagnosis
  • Mobile tech
  • Momtech
  • Monetization
  • Mortality
  • Natural language processing
  • Nhs
  • Nist
  • Nlp
  • Node health
  • Npi
  • Nurses
  • Nursing
  • Observational study
  • Ocr
  • Onc
  • Oncology
  • Ontology
  • Open source
  • Opinion
  • Otoscope
  • Pandemic
  • Parenting
  • Parkinson
  • Patents
  • Patient
  • Patient access
  • Patient billing
  • Patient data
  • Patient engagement
  • Patient experience
  • Patient identifier
  • Patient identity
  • Patient monitoring system
  • Patient privacy
  • Patient retention
  • Patient safety
  • Patient service
  • Patient voice
  • Patient wait time
  • Patients
  • Payer
  • Payers
  • Payment models
  • Pdmp
  • Pediatricians
  • Pharma
  • Pharmacy
  • Pharmacy app
  • Phi
  • Physician
  • Physician burnout
  • Pii
  • Podcast
  • Point of care
  • Policies
  • Population health
  • Post pandemic
  • Ppe
  • Precision medicine
  • Predictive analytics
  • Primary care
  • Privacy
  • Product regulation
  • Providers
  • Ptsd
  • Radiology
  • Radiomics
  • Ransomware
  • Rare diseases
  • Rcm
  • Registries
  • Remote care
  • Remote patient monitoring
  • Report
  • Reporting
  • Reports
  • Research
  • Retina
  • Revenue management
  • Rfid
  • Robotic process automation
  • Robotics
  • Robots
  • Roi
  • Rpa
  • Rpm
  • Rural health
  • Scribe
  • Sdoh
  • Security
  • Security breach
  • Slack
  • Smart phone
  • Smart wearables
  • Social determinants
  • Social media
  • Software
  • Sso
  • Startups
  • Stem cell
  • Study results
  • Survey
  • Technology
  • Telehealth
  • Telemedicine
  • Testing
  • Tokenization
  • Tools
  • Trends
  • Trump
  • Trump administration
  • Uber health
  • Urgent care
  • Usability
  • Ux
  • Vaccine
  • Vaccines
  • Value based care
  • Vendor management
  • Ventures
  • Video
  • Virtual care
  • Virtual event
  • Virtual monitoring
  • Virtual reality
  • Voice
  • Voice technology
  • Vr
  • Wearables
  • Wellness
  • Wellness and fitness trackers
  • Who
  • Womeninhit
  • Womens day
  • Womens health
Curated and published by
@ShahidNShah

Livongo's lead investor on what the next model of care could look like

When it comes to taking bets on what’s next in healthcare, investors are often the ones calling the shots. Hemant Taneja, managing director of General Catalyst, has sat in the driver’s seat on some of the biggest digital health deals. His firm has invested in a number of digital health companies, from behavioral health company Mindstrong to fitness startup Tempo. But perhaps Taneja’s is best known for his investing in chronic care startup Livongo.

Over the summer, the digital health world was abuzz with news that Livongo was scooped up by Teladoc in a historic $18.5 million merger. As lead investor, Taneja had a front-row seat to the evolution of the company. In fact, he and Livongo founder Glen Tullman sat down together and developed a business plan.

Posted Oct 12, 2020

#care model #investor

Femtech market has potential but struggles to score investor dollars

A new report from PitchBook projects solid growth in the industry, but also notes challenges in exits. Women’s health startups are starting to garner a lot of attention. However, a new report out of PitchBook found that the industry is still struggling to catch the attention of VCs, and has produced few exits.

“Only six femtech exits were completed in 2019; however, this still represents a 64% increase in exit value compared to 2018. The largest exits in recent years include Progyny’s (NASDAQ: PGNY) $130.0 million IPO and Procter & Gamble’s (NYSE: PG) acquisition of This Is L. for $100.0 million. Progyny’s stock has roughly doubled in the eight months since it went public,” the report reads.

Still, the authors of the report said that they see Femtech has a “solid growth outlook,” since there’s still many unmet needs in women’s health where tech could help.

As for funding, the report calculated that in 2019 femtech companies scored $592.1 million. That was down slightly from 2018’s $620.3 million. So far, in 2020, PitchBook recorded 57 deals and $376.2 million in venture dollars.

Posted Aug 31, 2020

#femtech #investor

What investors are saying about startups in the age of coronavirus

The novel coronavirus represents a global pandemic the likes of which haven’t been seen for roughly a century, and has put enormous pressures on the healthcare system and the economy alike.

To date the World Health Organization reports 209,839 confirmed cases and 8,778 deaths due to the virus. Healthcare providers and government agencies have scrambled to find ways to treat and stop the spread of the disease.

Digital health has quickly come onto the world stage – with telemedicine acting as a substitute for in-person visits, and chatbots filling in for nurse triage lines. However, like the rest of the world, the industry still faces an unknown financial future.

The pandemic has also caused major economic ripples. With the bulk of shops, restaurants and bars closed in the United States, the country could be facing soaring unemployment rates within the next year. Additionally, yesterday the stock market closed at a three-year low.

So what does the healthcare demand and the shaky financial footing mean for health tech startups? MobiHealthNews spoke to digital health investors, stakeholders and consultants about what the coronavirus will mean for startup investment, as well as about the opportunity and responsibility to contribute to this global crisis.

Posted Mar 23, 2020

#coronavirus #investor #startups

Publications

  • Netspective Media
  • The Healthcare IT Guy
  • Healthcare Guys
  • HITSphere
  • FEDSphere
  • Netspective CAK

Recent Posts

UK to begin using Oxford Covid vaccine as PM strikes hopeful tone
January 4, 2021
Our Favourite Digital Health Articles Of 2020
December 22, 2020
Top 10 EHR stories of 2020
December 22, 2020

Categories

CONTACT US

Thank you for your enquiry
The Field Required.
The Field Required.
© 2005-2021 Netspective Media LLC. All rights reserved.